Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
iScience ; 26(1): 105850, 2023 Jan 20.
Article in English | MEDLINE | ID: mdl-36636341

ABSTRACT

Lifespan is a life-history trait that undergoes natural selection. Telomeres are hallmarks of aging, and shortening rate predicts species lifespan, making telomere maintenance mechanisms throughout different lifespans a worthy topic for study. Alligators are suitable for the exploration of anti-aging molecular mechanisms, because they exhibit low or even negligible mortality in adults and no significant telomere shortening. Telomerase reverse transcriptase (TERT) expression is absent in the adult Alligator sinensis, as in humans. Selection analyses on telomere maintenance genes indicated that ATM, FANCE, SAMHD1, HMBOX1, NAT10, and MAP3K4 experienced positive selection on A. sinensis. Repressed pleiotropic ATM kinase in A. sinensis suggests their fitness optimum shift. In ATM downstream, Alternative Lengthening of Telomeres (ALT)-related genes were clustered in a higher expression pattern in A. sinensis, which covers 10-15% of human cancers showing no telomerase activities. In summary, we demonstrated how telomere shortening, telomerase activities, and ALT contributed to anti-aging strategies.

2.
AAPS PharmSciTech ; 21(6): 236, 2020 Aug 14.
Article in English | MEDLINE | ID: mdl-32803351

ABSTRACT

In recent years, with the aging of the population and the frequent use of electronic devices, many eye diseases have shown a linear upward trend, such as dry eye disease, glaucoma, cataract, age-related macular degeneration, and diabetic retinopathy. These diseases are often chronic and difficult to cure. Based on the structure and barrier of the human eye, this review describes the pathogenesis and treatments of several intractable eye diseases and summarizes the advanced ocular drug delivery systems to provide new treatment ideas for these diseases. Finally, we also look forward to the prospect of RNAi therapy in the treatment of eye diseases.


Subject(s)
Drug Delivery Systems/methods , Eye Diseases/drug therapy , Eye Diseases/metabolism , Adrenergic beta-Antagonists/administration & dosage , Adrenergic beta-Antagonists/metabolism , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/metabolism , Cataract/diagnosis , Cataract/drug therapy , Cataract/metabolism , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/drug therapy , Diabetic Retinopathy/metabolism , Dry Eye Syndromes/diagnosis , Dry Eye Syndromes/drug therapy , Dry Eye Syndromes/metabolism , Eye Diseases/diagnosis , Glaucoma/diagnosis , Glaucoma/drug therapy , Glaucoma/metabolism , Humans , Latanoprost/administration & dosage , Latanoprost/metabolism , Macular Degeneration/drug therapy , Macular Degeneration/epidemiology , Macular Degeneration/physiopathology , Photosensitizing Agents/administration & dosage , Photosensitizing Agents/metabolism , Timolol/administration & dosage , Timolol/metabolism , Treatment Outcome , Verteporfin/administration & dosage , Verteporfin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL